Health Affairs December 13, 2022
Eric J. Kutscher, S. Alex Sidelnik

As addiction medicine providers, we consider the recent announcement of a shortage of Adderall by the Food and Drug Administration (FDA) as cause for emergency. Adderall is traditionally not thought of as a life-saving medication but instead is usually considered only a drug designed to improve quality of life and decrease morbidity related to attention deficit hyperactivity disorder (ADHD). Yet, for those dependent upon its use (either for prescribed or recreational use), the absence of the medication may be life threatening—particularly in the era of a fentanyl-contaminated non-prescribed drug supply.

Over the past few decades, stimulant use has skyrocketed in the United States, raising alarms of another epidemic on the horizon. Amphetamine and methamphetamine use have found footholds in many...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Senior care centers should use data analytics to prioritize patient-centered care | Viewpoint
Medicare’s New Mandatory Bundled-Payment Program — Are We Ready for TEAM?
Your Friends Might Be Influencing Your Gut Microbiome: Study
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
Social epidemics and the role of physicians

Share This Article